The Centers for Disease Control and Prevention panel's meeting comes two days after the Food and Drug Administration announced it approved Pfizer and BioNTech's request to allow their vaccine to be given to young teens on an Emergency use Basis. The vaccine is already authorized for use in people 16 and older. It will be administered in adolescents in two doses, three weeks apart, the same regimen for 16 years of age and older, the FDA said.
What is the risk these teens are facing? With the death from Covid-19 reached 600,000 death and hospitalizations of millions, How many of these are teens?
Who is deciding the Risk out weigh the benefits for each individual. Just a thought.